Physician profile
James H Olson
NPI 1659357580
$754.67
in general payments reported to CMS, 2019-2025
19 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.75 · 2020: $37.30 · 2021: $169 · 2022: $124 · 2023: $86.12 · 2024: $103 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $143.57 | 2022-2025 | |
| Vertex Pharmaceuticals Incorporated | $122.73 | 2024-2025 | |
| Si-Bone, INC. | $114.01 | 2021-2024 | |
| Medtronic, INC. | $48.90 | 2021-2025 | Kyphon Express II Kyphopak Tray |
| Smith+Nephew, INC. | $48.60 | 2021-2023 | Legion, Synergy, Real Intelligence |
| Pfizer INC. | $38.55 | 2021 | |
| Amgen INC. | $24.80 | 2020 | |
| Solventum Corporation | $24.36 | 2025 | Prevena |
| Zimmer Biomet Holdings, INC. | $21.21 | 2021 | |
| Surgalign Spine Technologies, INC. | $20.98 | 2021 | |
| Cerapedics INC. | $19.74 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Depuy Synthes Sales INC. | $19.68 | 2022 | |
| Mimedx Group, INC. | $18.10 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $16.85 | 2019 | |
| Relievant Medsystems, INC. | $16.83 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $16.23 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $15.13 | 2022 | |
| Stryker Corporation | $12.50 | 2020 | |
| Scilex Pharmaceuticals INC. | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.